shutterstock_2055997766_michael_vi
Michael Vi / Shutterstock.com
31 May 2022AmericasSarah Speight

J&J units launch prostate cancer drug suit

Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada (apalutamide).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
15 February 2022   The US Court of Appeals for the Federal Circuit has affirmed two Patent Trial and Appeal Board rulings that a Johnson & Johnson subsidiary’s patent is valid and infringed.
Medtech
24 August 2021   The US Court of Appeals for the Federal Circuit has invalidated more claims of a Johnson & Johnson subsidiary’s surgical robot patent following a cross-appeal of a Patent Trial and Appeal Board decision.
Medtech
4 August 2022   Judge urges $18m award in ‘horrific’ counterfeiting case | Counterfeits were ‘bacterially contaminated’ | Ethicon.

More on this story

Medtech
15 February 2022   The US Court of Appeals for the Federal Circuit has affirmed two Patent Trial and Appeal Board rulings that a Johnson & Johnson subsidiary’s patent is valid and infringed.
Medtech
24 August 2021   The US Court of Appeals for the Federal Circuit has invalidated more claims of a Johnson & Johnson subsidiary’s surgical robot patent following a cross-appeal of a Patent Trial and Appeal Board decision.
Medtech
4 August 2022   Judge urges $18m award in ‘horrific’ counterfeiting case | Counterfeits were ‘bacterially contaminated’ | Ethicon.

More on this story

Medtech
15 February 2022   The US Court of Appeals for the Federal Circuit has affirmed two Patent Trial and Appeal Board rulings that a Johnson & Johnson subsidiary’s patent is valid and infringed.
Medtech
24 August 2021   The US Court of Appeals for the Federal Circuit has invalidated more claims of a Johnson & Johnson subsidiary’s surgical robot patent following a cross-appeal of a Patent Trial and Appeal Board decision.
Medtech
4 August 2022   Judge urges $18m award in ‘horrific’ counterfeiting case | Counterfeits were ‘bacterially contaminated’ | Ethicon.